Back to all news
Deep Learning Model Enables 3D Handheld Photoacoustic-Ultrasound Imaging Without Sensors
Pusan National University develops MoGLo-Net, an AI model that reconstructs 3D images from handheld 2D photoacoustic and ultrasound scans without external sensors.
Key Details
- 1MoGLo-Net uses deep learning to track handheld ultrasound transducer motion from tissue speckle data, eliminating need for external tracking hardware.
- 2Combines ResNet-based encoder and LSTM-based motion estimator for accurate motion tracking and 3D reconstruction.
- 3Validated using both proprietary and public datasets, outperforming state-of-the-art methods on all metrics.
- 4Successfully achieved 3D blood vessel reconstructions from combined ultrasound and photoacoustic data.
- 5Published June 13, 2025, in IEEE Transactions on Medical Imaging (DOI: 10.1109/TMI.2025.3579454).
- 6Innovation aims to make advanced 3D imaging safer, more accurate, and accessible without costly hardware.
Why It Matters
MoGLo-Net's ability to reconstruct 3D volumes from standard handheld imaging without external sensors could democratize high-end ultrasound and photoacoustic imaging, especially important in resource-limited settings. This advance may enable more effective diagnosis and real-time imaging guidance, expanding access to advanced imaging technologies while reducing costs and complexity of equipment.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.